Health care consequences of hospitalization with Clostrioides difficile infection: a propensity score matching study
- PMID: 35840929
- PMCID: PMC9287953
- DOI: 10.1186/s12879-022-07594-x
Health care consequences of hospitalization with Clostrioides difficile infection: a propensity score matching study
Abstract
Background: Clostridiodies difficile infection (CDI) has been characterized by the Center for Disease Control and Prevention (CDC) as an urgent public health threat and a major concern in hospital, outpatient and extended-care facilities worldwide.
Methods: A retrospective cohort study of patients aged ≥ 18 hospitalized with CDI in New York State (NYS) between January 1, 2014-December 31, 2016. Data were extracted from NY Statewide Planning and Research Cooperative (SPARCS) and propensity score matching was performed to achieve comparability of the CDI (exposure) and non-CDI (non-exposure) groups. Of the 3,714,486 hospitalizations, 28,874 incidence CDI cases were successfully matched to 28,874 non-exposures.
Results: The matched pairs comparison demonstrated that CDI cases were more likely to be readmitted to the hospital at 30 (28.26% vs. 19.46%), 60 (37.65% vs. 26.02%), 90 (42.93% vs. 30.43) and 120 days (46.47% vs. 33.74), had greater mortality rates at 7 (3.68% vs. 2.0%) and 180 days (20.54% vs. 11.96%), with significant increases in length of stay and total hospital charges (p < .001, respectively).
Conclusions: CDI is associated with a large burden on patients and health care systems, significantly increasing hospital utilization, costs and mortality.
Keywords: Clostridioides difficile infection; Hospitalizations; Mortality; SPARCS.
© 2022. The Author(s).
Conflict of interest statement
All authors have no conflict of interests to report.
Similar articles
-
Attributable costs and length of stay of hospital-acquired Clostridioides difficile: A population-based matched cohort study in Alberta, Canada.Infect Control Hosp Epidemiol. 2019 Oct;40(10):1135-1143. doi: 10.1017/ice.2019.178. Epub 2019 Jul 25. Infect Control Hosp Epidemiol. 2019. PMID: 31342884
-
Excess burden associated with Clostridioides difficile infection in haematological patients occurring during hospitalization with induction chemotherapy in the USA.J Hosp Infect. 2020 Apr;104(4):560-566. doi: 10.1016/j.jhin.2019.12.017. Epub 2019 Dec 20. J Hosp Infect. 2020. PMID: 31870888
-
Clostridium difficile infection is associated with increased risk of death and prolonged hospitalization in children.Clin Infect Dis. 2013 Jul;57(1):1-8. doi: 10.1093/cid/cit155. Epub 2013 Mar 26. Clin Infect Dis. 2013. PMID: 23532470 Free PMC article.
-
Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review.J Hosp Infect. 2014 Sep;88(1):12-21. doi: 10.1016/j.jhin.2014.04.011. Epub 2014 May 17. J Hosp Infect. 2014. PMID: 24996516 Review.
-
Clostridioides difficile infection increases in-hospital mortality, length of stay, and hospital cost but not 30-day mortality in cirrhotic patients.J Gastroenterol Hepatol. 2025 Jan;40(1):89-100. doi: 10.1111/jgh.16807. Epub 2024 Nov 13. J Gastroenterol Hepatol. 2025. PMID: 39538374 Review.
Cited by
-
Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm Trial.JAMA Netw Open. 2023 Feb 1;6(2):e2255758. doi: 10.1001/jamanetworkopen.2022.55758. JAMA Netw Open. 2023. PMID: 36780159 Free PMC article. Clinical Trial.
References
-
- Prevention C for DC and. Biggest Threats and Data | Antibiotic/Antimicrobial Resistance | CDC.
-
- Wilkins T, Sequoia J, Jennings W, Dorn B. Probiotics for gastrointestinal conditions: a summary of the evidence. Am Fam Phys. 2017;96:170–8. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources